Facebook SHR0302 (Ivarmacitinib) Market, 2032: How China's First Homegrown JAK1 Inhibitor Is Capturing the USD 1.22 Billion Autoimmune Opportunity
Logo

SHR0302 (Ivarmacitinib) Market, 2032: How China's First Homegrown JAK1 Inhibitor Is Capturing the USD 1.22 Billion Autoimmune Opportunity

クレジット
Avatar
インタビューワー
SHR0302 (Ivarmacitinib) Market, 2032: How China's First Homegrown JAK1 Inhibitor Is Capturing the USD 1.22 Billion Autoimmune Opportunity-1
シェア
金金の他の作品
foriio

あなたのforiioを無料で作成

fori.io/
SHR0302 (Ivarmacitinib) Market, 2032: How China's First Homegrown JAK1 Inhibitor Is Capturing the USD 1.22 Billion Autoimmune Opportunity-1
金金の他の作品
foriio

あなたのforiioを無料で作成

fori.io/